Need Career Advice

Struggling to make the decision between two options:

  1. Senior Associate at a distressed / turnaround focused PE shop in a Tier 2 City. All in initial comp at $325K. No carry, only coinvest. Would require me to move but allow me to stay in PE.
  2. VP at a restructuring consulting shop (think A&M, Alix, etc.) in my current Tier 1 City. All in initial comp $500K - $600K. No equity obviously, but you earn how much you bill so less dependent on partners ascribing you a bonus or carry. 

I guess the questions are. Is staying in PE worth it if I can make the same or even more cash comp in Rx consulting? Has anyone made a similar jump? Is coinvest only worth it? I'm a bit scarred by carry as I haven't heard of anyone I know ever actually get paid out carry. 

2 Comments
 

This is a classic dilemma between staying in Private Equity (PE) and transitioning to restructuring (Rx) consulting, and both options have their pros and cons. Here's a breakdown based on the most helpful WSO content:

Option 1: Senior Associate at a Distressed/Turnaround PE Shop

  • Compensation: $325K all-in with co-invest but no carry. Co-invest can be valuable, but it’s not guaranteed wealth. Carry, as you mentioned, is often elusive, and many mid-level professionals in PE share your skepticism about its payout.
  • Career Trajectory: Staying in PE keeps you on the path to potentially higher long-term earnings, especially if you can move upstream to a larger fund or eventually make Partner. However, as noted in WSO threads, promotions in PE can be slow and political, and the lack of carry here limits your upside.
  • Lifestyle: Tier 2 cities often offer a better cost of living, but moving can be disruptive. Additionally, PE can be more exhausting compared to consulting, with long hours and high pressure to deliver returns.
  • Risk: PE is inherently riskier. If the fund underperforms, your career progression and compensation could stagnate.

Option 2: VP at a Restructuring Consulting Shop

  • Compensation: $500K–$600K all-in is a significant jump in cash comp. While there’s no equity, the "eat what you kill" model gives you more control over your earnings, reducing dependency on firm politics or fund performance.
  • Career Trajectory: Rx consulting offers a more predictable path with opportunities to move up based on billable hours and performance. It’s also a skill set that can be leveraged across industries, providing flexibility if you decide to pivot later.
  • Lifestyle: Staying in your current Tier 1 city avoids the disruption of moving. However, Rx consulting can involve heavy travel and demanding hours, especially during active engagements.
  • Risk: Lower risk compared to PE. Your earnings are tied to your output rather than fund performance, and the demand for restructuring expertise tends to remain strong during economic downturns.

Key Considerations

  1. Is Staying in PE Worth It?

    • If your long-term goal is to make Partner and you’re willing to endure the grind, staying in PE might be worth it. However, without carry, the financial upside is limited, and co-invest alone may not justify the move.
    • If you’re already skeptical about carry and the politics of PE, Rx consulting might be a better fit, offering higher immediate comp and more control over your earnings.
  2. Has Anyone Made a Similar Jump?

    • Many professionals have transitioned from PE to consulting (and vice versa). Rx consulting is a natural pivot for those with PE experience, especially in distressed or turnaround situations. It’s a well-trodden path, and your PE background will likely be valued in Rx consulting.
  3. Is Co-Invest Only Worth It?

    • Co-invest can be valuable, but it’s not a substitute for carry. It requires you to put your own capital at risk, and the returns depend on the fund’s performance. If you’re already wary of carry payouts, co-invest might not provide the financial upside you’re seeking.

Final Thoughts

  • If you prioritize immediate cash comp and stability, the VP role in Rx consulting is the clear winner. It offers a significant pay bump, less reliance on fund performance, and avoids the disruption of moving.
  • If you’re committed to staying in PE and believe in the long-term potential of the distressed/turnaround space, the Senior Associate role could be worth it. However, the lack of carry and the need to relocate are notable downsides.

Ultimately, it comes down to your long-term goals and risk tolerance. If you’re leaning toward stability and higher immediate earnings, Rx consulting seems like the better choice. If you’re still passionate about PE and willing to take the risk, the Senior Associate role could keep you on that path.

Sources: Is this associate compensation competitive?, Moving Upstream in PE, Leave PE for Corp Dev VP role?, Private Equity vs Consulting?, To all Consultants considering PE

I'm an AI bot trained on the most helpful WSO content across 17+ years.
 

Et consequatur voluptatibus voluptatibus. Sit debitis distinctio et omnis at nostrum debitis ipsa. Occaecati sint dolor omnis molestiae non esse. Pariatur sapiente incidunt ipsam nulla non. Nihil delectus impedit sequi doloribus.

Non est itaque consectetur ut ipsa dolorem consectetur. Eaque at ducimus odio enim. Ab dolor consequatur et odit sed harum minima unde. Ut sed enim eaque. Non architecto laborum in doloremque eos placeat.

Career Advancement Opportunities

June 2026 Private Equity

  • The Riverside Company 99.6%
  • KKR (Kohlberg Kravis Roberts) 99.2%
  • Blackstone Group 98.9%
  • Warburg Pincus 98.5%
  • Bain Capital 98.1%

Overall Employee Satisfaction

June 2026 Private Equity

  • KKR (Kohlberg Kravis Roberts) 99.6%
  • The Riverside Company 99.2%
  • Ardian 98.9%
  • Blackstone Group 98.5%
  • Starwood Capital Group 98.1%

Professional Growth Opportunities

June 2026 Private Equity

  • Bain Capital 99.6%
  • The Riverside Company 99.2%
  • Blackstone Group 98.9%
  • Starwood Capital Group 98.5%
  • KKR (Kohlberg Kravis Roberts) 98.1%

Total Avg Compensation

June 2026 Private Equity

  • Principal (9) $653
  • Director/MD (24) $547
  • Vice President (97) $363
  • 3rd+ Year Associate (104) $281
  • 2nd Year Associate (234) $272
  • 1st Year Associate (411) $229
  • 3rd+ Year Analyst (33) $157
  • 2nd Year Analyst (95) $134
  • 1st Year Analyst (271) $124
  • Intern/Summer Associate (37) $80
  • Intern/Summer Analyst (351) $61
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
kanon's picture
kanon
99.0
5
CompBanker's picture
CompBanker
98.9
6
Betsy Massar's picture
Betsy Massar
98.9
7
DrApeman's picture
DrApeman
98.9
8
dosk17's picture
dosk17
98.9
9
GameTheory's picture
GameTheory
98.9
10
Mimbs's picture
Mimbs
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”